临床药师参与1例肝硬化合并门静脉血栓形成的抗凝药物治疗实践  

Practice of Clinical Pharmacist Participating in a Case of Anticoagulant Therapy for Liver Cirrhosis with Portal Vein Thrombosis

作　　者：李芸[1,2] 宋育林[3] 汪燕燕[2] Li Yun;Song Yulin;Wang Yanyan(Department of Pharmacy,the First Affiliated Hospital of Soochow University,Suzhou 215006,Jiangsu,China;Department of Pharmacy,the First Affiliated Hospital of Anhui Medical University;Department of Gastroenterology,the First Affiliated Hospital of Anhui Medical University)

机构地区：[1]苏州大学附属第一医院药学部 [2]安徽医科大学第一附属医院药剂科 [3]安徽医科大学第一附属医院消化内科

出　　处：《药物流行病学杂志》2020年第12期843-847,共5页Chinese Journal of Pharmacoepidemiology

摘　　要：临床药师参与1例肝硬化合并门静脉血栓形成的抗凝药物治疗和监护。收集患者病史信息,查阅国内外文献,协助医生评估该患者是否需要抗凝治疗,探讨患者抗凝治疗的时机、药物选择、剂量调整和疗程,给与用药建议并持续监护患者情况。在随访药物疗效和安全性的基础上对可疑的药物不良反应进行分析。改善了患者预后,提升用药安全性,为临床提供参考。Clinical pharmacists participated in anticoagulant therapy and monitoring of a patient with cirrhosis complicated with portal vein thrombosis.By collecting the patient’s medical history,reviewing domestic and foreign literature,assisting doctors to assess whether the patient needs anticoagulant therapy,discussing the timing,drug selection,dose adjustment and treatment course of the anticoagulant therapy,giving medication advice and continuously monitoring the patient’s condition.Based on the follow-up of the efficacy and safety of the drug,the suspicious adverse drug reactions were analyzed.It can improve the prognosis of patients,enhance the safety of medication,and provide reference for clinical practice.

关 键 词：肝硬化 门静脉血栓 抗凝治疗 临床药师 药学监护 

分 类 号：R97[医药卫生—药品]